NYSE$NHI

National Health Investors Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

NHI's financial performance decreased slightly due to the COVID-19 pandemic.

National Health Investors (NHI) reported a decrease in net income per share for Q4 2020 compared to the same period in the prior year. The company's normalized FFO per share also decreased slightly, while normalized AFFO per share remained unchanged. Despite challenges posed by the COVID-19 pandemic, NHI highlighted its strong collection rates and investments made during the year.

  • Net income attributable to common stockholders per diluted common share decreased by 12.6% to $0.83.
  • Normalized FFO per diluted common share decreased by 2.8% to $1.37.
  • Normalized AFFO per diluted common share remained unchanged at $1.30.
  • Collected 93.9% of contractual cash due for the fourth quarter.

Headline financials

Total Revenue

$81.2M

Previous: $82.2M-1.2%
EPS (adj)

$1.37

Previous: $1.41-2.8%
Capital Expenditures

$117M

Previous: $237M-50.8%
Free Cash Flow

-$61.1M

Previous: -$181M+66.2%
Net Income

$37.2M

Previous: $42M-11.6%
Operating Income

$37.2M

Previous: $42.9M-13.3%
Gross Profit

$78.8M

Previous: $80.6M-2.3%
Cash & Equivalents

$43.3M

Previous: $5.22M+731.1%
Total Assets

$3.12B

Previous: $2.96B+5.6%
Stock-Based Comp

$5.45M

No prior period

Revenue & EPS history

NHI · Revenue · Quarterly

$81.2M

Q4 2020-1.2%vs Q4 2019
Beat estimate in 5 of 16 quarters(31%)
ActualEstimate

Revenue by segment

NHI · $81.2M total across 2 segments · Q4 2020

  • Rental income
    $74.9M-0.6%
  • Interest income and other
    $6.3M-7.3%

Forward guidance

Due to the uncertain impact of the COVID-19 pandemic on the senior housing and skilled nursing industries, NHI is not providing guidance at this time. They anticipate 2021 will be a challenging year, but the vaccine rollout is expected to have a positive impact on occupancy.

Tailwinds

  • Vaccine rollout is having a positive impact with declining numbers of infected buildings and active resident cases.
  • Expect occupancy will inflect at some point in 2021.
  • Company is well positioned to weather the storm with multiple levers at its disposal.
  • Company is set up for longer term growth.
  • Collections remained strong throughout 2020 and into 2021.

Headwinds

  • The pandemic has placed a considerable burden on the senior housing and skilled nursing industries.
  • Visibility is clouded in the months ahead.
  • 2021 will be a more challenging year.
  • The road to recovery is uncertain.
  • Damage is irreparable and remain steadfast in our positive outlook for senior housing and skilled nursing.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+1.3%

Avg return

30 days after

59%

40 / 68 earnings

Positive

+14.9%

Q3 2020

Best reaction

-7.9%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.9%-9.4%
Q4 2025-4.2%-3.2%-6.3%
Q3 2025+1.8%+1.1%+4.1%
Q1 2025+0.5%+1.0%-6.2%
Q4 2024-0.2%+2.9%+4.8%
Q3 2024+1.1%+7.0%-0.4%
Q2 2024+3.0%+3.2%+13.8%
Q1 2024+1.4%+0.9%+2.8%
Q4 2023+6.6%+8.4%+16.5%
Q3 2023+0.5%-0.7%+7.8%
Q2 2023-7.5%-6.7%-9.4%
Q1 2023+7.6%+8.3%+8.0%
Q4 2022-7.9%-6.5%-17.5%
Q3 2022-1.4%+3.4%+2.1%
Q2 2022+2.6%+4.9%+4.5%
Q1 2022-3.4%+1.4%+12.8%
Q4 2021-3.2%-2.0%+6.4%
Q3 2021+1.4%+1.8%+1.4%
Q2 2021-6.2%-5.5%-9.7%
Q1 2021-3.1%-4.9%-5.6%
Q4 2020-0.6%+0.1%+7.5%
Q3 2020+14.9%+18.0%+20.7%
Q2 2020+0.1%-2.8%-1.0%
Q1 2020-4.2%-11.3%+19.2%
Q4 2019+1.4%+1.8%-57.5%
Q3 2019-2.0%-2.0%+1.0%
Q2 2019+2.1%+2.0%+3.9%
Q1 2019-1.2%+0.8%+3.4%
Q4 2018-6.9%-4.0%-5.7%
Q3 2018+1.6%+2.4%+8.0%
Q2 2018+1.0%+0.1%+3.1%
Q1 2018+1.9%+1.7%+6.7%
Q4 2017+0.0%+0.8%+7.5%
Q3 2017-2.9%-1.5%-0.6%
Q2 2017+1.0%+2.8%+6.7%
Q1 2017+2.5%+4.4%+5.1%
Q4 2016+0.7%+1.1%-3.9%
Q3 2016-0.3%-5.5%+1.1%
Q2 2016+0.6%+2.0%+3.4%
Q1 2016+1.9%
Q4 2015+3.8%
Q3 2015-0.1%
Q2 2015-1.9%
Q1 2015+1.5%
Q4 2014+0.4%
Q3 2014-0.7%
Q2 2014+2.6%
Q1 2014+1.5%
Q4 2013-1.0%
Q3 2013-0.7%
Q2 2013-0.0%
Q1 2013+3.3%
Q4 2012-1.1%
Q3 2012+1.3%
Q2 2012-2.7%
Q1 2012+1.2%
Q4 2011-2.4%
Q3 2011+0.8%
Q2 2011-5.4%
Q1 2010-2.5%
Q1 2011+0.1%
Q4 2008+0.2%
Q4 2010+0.2%
Q3 2010+1.6%
Q3 2009+1.6%
Q2 2010+0.9%
Q2 2009+0.9%
Q4 2009+0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro